Clinical Trials Insight: 700028680

Trial Profile

Clinical Trials Insight: 700028680

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 05 Mar 2010

At a glance

  • Drugs Herpes simplex vaccine; ImmunoVEX HSV2
  • Indications Herpes genitalis; Herpes simplex virus type 2 infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors BioVex
  • Most Recent Events

    • 05 Mar 2010 Status changed from recruiting to active, no longer recruiting, as reported by BioVex.
    • 05 Mar 2010 Results data are expected in late 2010, as reported by BioVex.
    • 20 Aug 2008 Status change from planning to initiated, according to a BioVex media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top